Publicaciones en colaboración con investigadores/as de University of California, San Diego (30)

2025

  1. Exploring the pathways linking prenatal and early childhood greenness exposure to attention-deficit/hyperactivity disorder symptoms during childhood: An approach based on robust causal inference

    International Journal of Hygiene and Environmental Health, Vol. 263

2024

  1. Clinical and neuroradiological spectrum of biallelic variants in NOTCH3

    eBioMedicine, Vol. 107

  2. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

  3. Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts

    npj Parkinson's Disease, Vol. 10, Núm. 1

  4. The heat-mortality association in Jordan: Effect modification by greenness, population density and urbanization level

    Science of the Total Environment, Vol. 952

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Natural history of liver disease in a large international cohort of children with Alagille syndrome: Results from the GALA study

    Hepatology, Vol. 77, Núm. 2, pp. 512-529

2022

  1. Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort

    npj Parkinson's Disease, Vol. 8, Núm. 1

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis

    Journal of Hepatology, Vol. 74, Núm. 1, pp. 20-30

2020

  1. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study

    The Lancet Neurology, Vol. 19, Núm. 1, pp. 71-80

2019

  1. Extracellular Vesicles in Liver Diseases: Meeting Report from the International Liver Congress 2018

    Hepatology Communications, Vol. 3, Núm. 2, pp. 305-315

  2. Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)

    Parkinsonism and Related Disorders, Vol. 62, pp. 201-209

  3. Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors

    Nature Genetics, Vol. 51, Núm. 5, pp. 804-814

  4. Mechanisms underlying resilience in ageing

    Nature Reviews Neuroscience

  5. Metformin results in diametrically opposed effects by targeting non-stem cancer cells but protecting cancer stem cells in head and neck squamous cell carcinoma

    International Journal of Molecular Sciences, Vol. 20, Núm. 1

2018

  1. The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort

    Annals of Clinical and Translational Neurology, Vol. 5, Núm. 12, pp. 1460-1477

2016

  1. Immune cell screening of a nanoparticle library improves atherosclerosis therapy

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 113, Núm. 44, pp. E6731-E6740

2015

  1. Designing a broad-spectrum integrative approach for cancer prevention and treatment

    Seminars in Cancer Biology, Vol. 35, pp. S276-S304

  2. Transcriptional repression by the HDAC4-RelB-p52 complex regulates multiple myeloma survival and growth

    Nature Communications, Vol. 6